Decoy Therapeutics Inc. Company Profile
NASDAQ: DCOYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:11 AM ET
Decoy Therapeutics at a glance
Decoy Therapeutics Inc. (NASDAQ: DCOY) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Houston, TX. Decoy Therapeutics is led by Mr. Frederick E. Pierce II and employs about 11 people. The company's shares have traded publicly since 2015.
At a market capitalization of $995,881, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001615219, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Decoy Therapeutics do?
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas.
Business description based on the company's public filings.
Company information
- Legal name
- Decoy Therapeutics Inc.
- Ticker
- NASDAQ: DCOY
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Frederick E. Pierce II
- Employees
- 11
- Headquarters
- 2450 Holcombe Blvd, Houston, TX, United States
- Phone
- 713 913 5608
- Website
- decoytx.com
- IPO year
- 2015
- Market cap
- $995.88K
- SEC CIK
- 0001615219
Companies similar to Decoy Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BDRXBiodexa Pharmaceuticals plc American Depositary Shs | 0.4914 | -6.17% | $1.08M | vs DCOY |
| SBFMSunshine Biopharma Inc. | 0.3859 | -10.39% | $1.66M | vs DCOY |
| SXTCChina SXT Pharmaceuticals Inc. Class A | 0.1839 | -46.46% | $243.01K | vs DCOY |
| ARTLArtelo Biosciences Inc. | 3.38 | +0.30% | $1.85M | vs DCOY |
| MDCXMedicus Pharma Ltd. | 0.0908 | -10.87% | $136.12K | vs DCOY |
| LABTLakewood-Amedex Biotherapeutics Inc. | 0.79 | -0.25% | $1.87M | vs DCOY |
| CDTCDT Equity Inc. | 0.7102 | -11.22% | $28.79K | vs DCOY |
| PBMPsyence Biomedical Ltd. | 4.99 | -2.39% | — | vs DCOY |